Advertisement Lescarden signs distribution agreement with Philusa - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Lescarden signs distribution agreement with Philusa

US-based biotechnology company has signed a distribution agreement with Philusa, a distributor of drug and personal care products in the Philippines.

Under the terms of the agreement, Philusa will have exclusive rights to the marketing and distribution of Lescarden’s Repliderm burn relief line of consumer products for cuts, minor burns and wounds.

The companies are completing the required marketing application to the Filipino Bureau of Food and Drug regulatory authorities. It is anticipated that the marketing of Repliderm will commence by the second quarter of 2009.

William Luther, president and CEO of Lescarden, said: “The introduction of the Repliderm line to consumers in the Philippines is an important step forward. This will be the first time a Catrix-based skin care product will be available to the mass retail market.

“We are pleased to be working with Philusa, which has established itself as the leader in the marketing and distribution of health and personal care products in the Philippines.”